XML 64 R34.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Divestitures and Assets Held for Sale (Details 1) (USD $)
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Jan. 31, 2011
Mar. 31, 2011
Jun. 30, 2011
Jun. 30, 2010
Dec. 31, 2010
Jan. 03, 2011
Divestitures and Assets Held For Sale (Textuals) [Abstract]            
Purchase price for divestiture of business/controlling interest $ 1,500,000,000          
Proceeds from divestiture of business, including amount placed in escrow 1,450,000,000          
Proceeds from divestitures of businesses 1,426,000,000   1,417,000,000 0    
Amount placed into escrow 24,000,000          
Contingent receivable for divestiture of business     50,000,000      
Approximate period of transfer or separation of certain manufacturing facilities 24 months          
Revenues generated by the Neurovascular business as a percentage of our consolidated net sales         340,000,000  
Percentage of Revenue Generated by Divested Business         4.00%  
Liabilities assumed by Strkyer in divestiture           0
Assets held for sale, property, plant and equipment     3,000,000   5,000,000  
Gain on divestiture of business   760,000,000        
Gain on divestiture of business, net of tax   530,000,000        
Deferred gain to be recognized upon the release of escrowed funds   27,000,000        
Neurovascular business [Member]
           
Divestitures and Assets Held For Sale (Textuals) [Abstract]            
Assets held for sale, property, plant and equipment         $ 4,000,000